The Centers for Medicare & Medicaid Services (CMS) just released the annual Landscape Files containing data on plan participation, beneficiary premiums, and benefit designs for the 2018 Part D — Medicare's prescription drug benefit — and Medicare Advantage (MA) markets.
Avalere has updated its previous analysis to reflect the September 25 version of the Graham-Cassidy-Heller-Johnson (GCHJ) bill to repeal and replace the Affordable Care Act (ACA).
New analysis from Avalere finds that the Graham-Cassidy-Heller-Johnson (GCHJ) bill to repeal and replace the Affordable Care Act (ACA) would lead to a substantial reduction in federal Medicaid funding to states of $713B through 2026 and more than $3.5T over a 20-year period if block grant funding is not reauthorized (Figure 1).
Avalere experts discuss the need for unique stakeholder collaborations to facilitate success in the transition to a value-based care system.
New analysis from Avalere finds that the Graham-Cassidy-Heller-Johnson (GCHJ) bill to repeal and replace the Affordable Care Act (ACA) would lead to a reduction in federal funding to states by $215B through 2026 and more than $4T over a 20-year period (Table 1).
Avalere's President and Founder, Dan Mendelson, recently wrote a column about the new strategies that device manufacturers should take in this era of healthcare.
Market stabilization efforts could also lead to higher enrollment in exchanges.
Benefit designs do not vary widely based on insurer competition, except for deductibles that are lower in areas with three or more insurers.
The FDA Reauthorization Act of 2017 (FDARA), which was signed into law on August 18, 2017, calls on FDA to examine underlying barriers to access to investigational drugs.
Avalere recently partnered with the National Association of Chain Drug Stores (NACDS) to explore the role that pharmacists can play in the uptake of seasonal influenza immunizations.
Today, the Senate voted to pass H.R.2430, the FDA Reauthorization Act of 2017.
On July 31, the Centers for Medicare & Medicaid Services (CMS) announced that the base Part D premium will be $35 for 2018.
Affordable Care Act-compliant plan market would see 39% higher premiums, while non–ACA-compliant plans would have much lower premiums
Avalere simulation finds that more ACOs will be eligible for earnings if they take on two-sided risk.
As the Senate prepares to begin debate on a revised version of the Better Care Reconciliation Act (BCRA) next week, Avalere offers the following observations on select components of the legislation:
Elizabeth Carpenter, Senior Vice President, will present on July 15 at the National Governors Association Summer Meeting in Providence, RI, in a governors-only session entitled “The Future of Health Care.”
Today, the Medicare Trustees delivered to Congress their annual report on the financial operations and status of the program.
In our digital health series, we explore the role innovation and technology play in the healthcare landscape. We interview Sajid Ahmed, Chief Information & Innovation Officer of the new Martin Luther King Jr. Community Hospital. Hear how he leads its greater than $70 million health information technology initiative and launched the innovation hub that serves 1.35 million residents from all over South Los Angeles.
New research from Avalere finds that most health plans are covering at least one of the two biosimilar products currently on the market.
Our experts discuss the key differences making the the Patient-Perspective Value Framework 1.0 (PPVF) unique compared to value frameworks currently in the market.
